PI3K

CAT # Izina ryibicuruzwa Ibisobanuro
CPD1573 GDC-0077 GDC-0077 ni munzira iboneka ya PI3K inhibitor hamwe nibikorwa bya antineoplastique.
CPD1022 IPI-549 IPI549 ni Inhibitor ikomeye kandi ihitamo PI3Kγ ifite IC50 ya 16 nM.
CPDD3857 GDC-0326 GDC-0326 ni inhibitor ikomeye kandi ihitamo α-Isoform ya Phosphoinositide 3-Kinase (PI3Kalpha inhibitor). GDC-0326 igera kurwego rwo hejuru cyane rwo guhitamo kurenza izindi kinase. GDC-0326 ifite plasma nkeya CL mubantu.
CPDB0202 AZD8186 AZD8186 ni na inhibitor ya beta isoform ya fosifinositide-3 kinase (PI3K), hamwe nibikorwa bya antineoplastique.
CPDB1536 PQR530 PQR530 ninzitizi ikomeye cyane pan-PI3K / mTORC1 / 2 inhibitor.
CPDB1573 GDC-0077 GDC-0077 ni munwa iboneka kandi ihitamo PI3K inhibitor (IC50 = 0.038 + 0.003 nM) hamwe> guhitamo inshuro 300 kurenza ayandi masomo ya I PI3K.
Ese?

Twandikire

Itohoza

Amakuru agezweho

  • Inzira 7 Zambere Mubushakashatsi bwa Farumasi Muri 2018

    Inzira 7 Zambere Mubushakashatsi bwa Farumasi I ...

    Kuba uri munsi yigitutu cyinshi kugirango duhatane mubibazo bitoroshye byubukungu n’ikoranabuhanga, uruganda rukora imiti n’ibinyabuzima rugomba guhora rushya muri gahunda zabo za R&D kugirango rukomeze imbere ...

  • ARS-1620: Kanseri nshya ya KRAS-mutant

    ARS-1620: Inhibitor nshya itanga ikizere kuri K ...

    Nk’uko ubushakashatsi bwasohotse mu Kagari bubitangaza, abashakashatsi bakoze inzitizi yihariye ya KRASG12C yitwa ARS-1602 itera ibibyimba gusubira mu mbeba. "Ubu bushakashatsi butanga muri vivo ibimenyetso byerekana ko mutant KRAS ishobora kuba ...

  • AstraZeneca yakira imbaraga zo kugenzura imiti ya oncology

    AstraZeneca yakira imbaraga zo kugenzura ...

    Ku wa kabiri, AstraZeneca yakiriye inshuro ebyiri mu nshingano zayo za oncology, nyuma y’uko abagenzuzi b’Amerika n’Uburayi bemeye gutanga amabwiriza agenga imiti y’ibiyobyabwenge, intambwe yambere yo gutsindira kwemerwa niyi miti. ...

Ikiganiro cya WhatsApp Kumurongo!